Detalhe da pesquisa
1.
Identifying predictors of resilience to stressors in single-arm studies of pre-post change.
Biostatistics;
2023 Aug 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37542423
2.
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.
Blood;
139(4): 608-623, 2022 01 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34657151
3.
Assessing Heterogeneity of Treatment Effect in Real-World Data.
Ann Intern Med;
176(4): 536-544, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36940440
4.
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine.
Haematologica;
108(7): 1886-1899, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36519323
5.
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Haematologica;
108(12): 3321-3332, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37408464
6.
Clinical trial participation predicts improved survival in older adults receiving allogeneic blood and marrow transplant.
BMC Geriatr;
23(1): 120, 2023 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36869287
7.
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.
J Oncol Pharm Pract;
28(6): 1340-1349, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34134554
8.
Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study.
Ann Intern Med;
174(9): 1207-1213, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34224261
9.
Gender-related differences in the outcomes and genomic landscape of patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
Br J Haematol;
193(6): 1142-1150, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34028801
10.
Individualized treatment effects with censored data via fully nonparametric Bayesian accelerated failure time models.
Biostatistics;
21(1): 50-68, 2020 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30052809
11.
Lasso estimation of hierarchical interactions for analyzing heterogeneity of treatment effect.
Stat Med;
40(25): 5417-5433, 2021 11 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34240443
12.
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.
Ann Intern Med;
172(1): W1-W25, 2020 01 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31711094
13.
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement.
Ann Intern Med;
172(1): 35-45, 2020 01 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31711134
14.
Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Keynote and panel discussion on communicating heterogeneous treatment effects across populations.
Pharm Stat;
20(5): 965-978, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33942971
15.
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study.
Biol Blood Marrow Transplant;
26(9): 1679-1688, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32592857
16.
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant;
26(12): 2306-2310, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32961372
17.
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia.
Biol Blood Marrow Transplant;
26(3): 502-508, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31730920
18.
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.
CMAJ;
192(32): E901-E906, 2020 Aug 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32778601
19.
Diminished ovarian reserve in young women with sickle cell anemia.
Blood;
139(7): 1111-1115, 2022 02 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34864892
20.
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Blood;
129(10): 1389-1393, 2017 03 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28049637